Early Recognition and Management of Stroke: A Comprehensive Review for Clinicians

Abstract

Stroke remains a leading cause of morbidity and mortality worldwide, demanding urgent recognition and intervention to optimize patient outcomes. This review synthesizes current evidence on the early recognition and management of stroke, encompassing epidemiology, pathophysiology, risk factors, clinical presentation, diagnostic strategies, acute and ongoing therapies, and recent advances. Emphasis is placed on integrating guideline-based recommendations with practical, mechanism-driven approaches for front-line healthcare professionals.

Introduction

Stroke is a cerebrovascular event characterized by sudden-onset neurological deficit due to either ischemic or hemorrhagic etiologies. Timely identification and management of stroke are paramount, as the therapeutic window for interventions such as thrombolysis and thrombectomy is narrow. Advances in neuroimaging, acute care protocols, and preventive strategies have significantly impacted stroke outcomes. This article provides an in-depth review for clinicians, consolidating the latest scientific evidence and consensus guidelines to facilitate best practices in stroke care.

Epidemiology / Disease Burden

Globally, stroke is the second leading cause of death and a major contributor to long-term disability. According to World Health Organization data, over 12 million people experience a stroke each year, with nearly 6.5 million deaths attributed to stroke-related complications. The incidence and prevalence of stroke are rising in low- and middle-income countries, partly due to aging populations and increased prevalence of vascular risk factors. The economic burden is immense, encompassing direct healthcare costs and indirect losses from disability and caregiver needs. Early recognition and optimized management remain critical to reducing the disease burden and improving functional outcomes.

Pathophysiology

Stroke is broadly categorized into ischemic (approximately 85% of cases) and hemorrhagic (15%) types. Ischemic stroke results from cerebral artery occlusion, leading to a cascade of cellular energy failure, excitotoxicity, oxidative stress, and neuroinflammation. The ischemic penumbra—viable tissue at risk—represents a key target for therapeutic intervention. Hemorrhagic stroke occurs due to rupture of cerebral vessels, causing direct tissue injury, mass effect, and secondary ischemia. Mechanistic understanding of these processes has guided the development of targeted therapies and monitoring strategies.

Risk Factors

Major modifiable risk factors include hypertension, atrial fibrillation, diabetes mellitus, dyslipidemia, smoking, and physical inactivity. Non-modifiable factors encompass age, sex, ethnicity, and genetic predisposition. Recent research highlights the interplay between vascular comorbidities and systemic inflammation in stroke pathogenesis. Identification and management of atrial fibrillation and carotid atherosclerosis are particularly important in reducing recurrent events. Emerging risk factors, such as sleep-disordered breathing and chronic kidney disease, are gaining recognition in contemporary guidelines.

Clinical Features

Stroke typically presents with sudden-onset focal neurological deficits. Classic symptoms include unilateral weakness or numbness, facial droop, dysarthria, aphasia, visual disturbances, and loss of coordination. Large vessel occlusions may manifest as severe hemiparesis, gaze deviation, or cortical signs, while posterior circulation strokes can present with ataxia, vertigo, and cranial nerve deficits. Recognition of atypical presentations and transient ischemic attacks (TIAs) is crucial, as these may precede major strokes. Standardized tools such as the FAST (Face, Arm, Speech, Time) and NIH Stroke Scale aid in rapid and objective assessment.

Diagnosis

Diagnosis of stroke hinges on clinical evaluation supported by neuroimaging. Non-contrast computed tomography (CT) is the first-line modality to differentiate ischemic from hemorrhagic stroke. Magnetic resonance imaging (MRI) with diffusion-weighted imaging offers superior sensitivity for early ischemic changes and posterior fossa strokes. Vascular imaging (CT angiography, MR angiography) identifies large vessel occlusions amenable to mechanical thrombectomy. Laboratory investigations, including blood glucose, coagulation profile, and cardiac markers, are essential to exclude mimics and guide therapy. Rapid triage and streamlined protocols, such as stroke code activation, minimize delays in diagnosis and treatment initiation.

Treatment & Management

Acute management is time-critical. For eligible patients, intravenous thrombolysis with alteplase is recommended within 4.5 hours of symptom onset, provided contraindications are excluded. Endovascular thrombectomy is indicated for select patients with large vessel occlusion up to 24 hours, based on imaging criteria. Blood pressure control, antiplatelet or anticoagulant therapy, and monitoring for complications (e.g., cerebral edema, hemorrhagic transformation) are essential elements of care. Hemorrhagic stroke management focuses on blood pressure control, reversal of coagulopathy, and neurosurgical intervention if indicated. Secondary prevention strategies include antithrombotic therapy, statins, lifestyle modification, and management of vascular risk factors.

Recent Advances / Emerging Therapies

Recent advances include extended time windows for thrombectomy based on perfusion imaging, novel antithrombotic agents, and individualized blood pressure targets. Mobile stroke units equipped with point-of-care imaging and telemedicine capabilities have shown promise in reducing treatment delays. Ongoing research explores neuroprotective agents, stem-cell therapies, and advanced neurorehabilitation techniques. Artificial intelligence-driven imaging analysis may further improve diagnostic accuracy and triage in the near future.

Guideline Recommendations

Current guidelines from the American Heart Association/American Stroke Association (AHA/ASA) and European Stroke Organisation (ESO) emphasize rapid recognition, imaging, and evidence-based acute interventions. Key recommendations include pre-hospital notification, door-to-needle time targets, stroke unit admission, and comprehensive secondary prevention. Multidisciplinary approaches, involving neurologists, emergency physicians, radiologists, and rehabilitation specialists, are essential for optimal care delivery.

Conclusion

Early recognition and management of stroke are pivotal in reducing mortality and improving long-term neurological outcomes. Adherence to guideline-based protocols, combined with ongoing incorporation of recent advances, ensures that clinicians deliver the highest standard of care. Continued research, education, and system-level improvements are necessary to further optimize stroke care and address the global burden of this devastating disease.